CCM
GILD icon

Condor Capital Management’s Gilead Sciences GILD Stock Holding History

Condor Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-11,202
Closed -$802K – 180
2016
Q4 		$802K Sell
11,202
-90
-0.8% -$6.69K 0.18% 121
2016
Q3 		$893K Buy
11,292
+68
+0.6% +$5.52K 0.21% 110
2016
Q2 		$936K Buy
11,224
+751
+7% +$66.6K 0.22% 107
2016
Q1 		$962K Buy
10,473
+209
+2% +$18.8K 0.23% 104
2015
Q4 		$1.04M Sell
10,264
-212
-2% -$22.1K 0.25% 96
2015
Q3 		$1.03M Buy
10,476
+202
+2% +$22.4K 0.27% 96
2015
Q2 		$1.2M Buy
10,274
+104
+1% +$11.4K 0.29% 94
2015
Q1 		$998K Buy
10,170
+204
+2% +$20.7K 0.24% 113
2014
Q4 		$939K Sell
9,966
-221
-2% -$22.9K 0.26% 101
2014
Q3 		$1.08M Sell
10,187
-155
-1% -$15.2K 0.3% 94
2014
Q2 		$857K Buy
+10,342
New +$805K 0.24% 104

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Condor Capital Management's GILD Position: Q1 2017 in Review

Condor Capital Management sold out of Gilead Sciences (GILD) in Q1 2017, closing a stake of 11,202 shares — an estimated $802K sold.

Condor Capital Management first reported a position in GILD in Q2 2014 and held it in 11 quarters. The position peaked at $1.2M in Q2 2015. 1,524 funds tracked by Wall St. Rank hold GILD as of Q1 2017.

  • Condor Capital Management reported no remaining Gilead Sciences position as of Q1 2017 after selling out during the quarter.
  • Condor Capital Management sold 11,202 Gilead Sciences shares in Q1 2017, an estimated $802K.
  • Condor Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 11 quarters.
  • Condor Capital Management's Gilead Sciences position peaked at $1.2M in Q2 2015.
  • 1,524 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2017.

Based on Condor Capital Management's 13F filing for Q1 2017, filed 9 May 2017.